Position in FHTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,445,025
+$390,764 QoQ
Shares Held
910,866
+7.4% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. FHTX ranks #253 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in FHTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,445,025 | 910,866 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,054,261 | 848,172 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,293,215 | 795,040 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,953,505 | 808,488 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,796,067 | 807,674 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,521,036 | 690,695 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,223,113 | 682,863 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,306,463 | 677,386 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,053,882 | 531,110 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $3,008,837 | 448,411 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,891,857 | 448,350 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,130,410 | 426,082 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,862,097 | 406,548 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,393,249 | 386,008 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,362,188 | 370,249 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,162,819 | 368,627 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,848,495 | 356,507 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,333,302 | 350,184 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,944,923 | 347,395 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,798,808 | 272,707 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,536,728 | 237,744 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,932,715 | 146,640 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,686,018 | 132,512 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||